Lupin launches triple-drug inhaler for COPD in India

Lupin has launched Formoflo-G MDI, a fixed-dose triple-combination inhaler for moderate to severe COPD in India. The product combines Glycopyrronium Bromide, Formoterol Fumarate and Fluticasone Propionate in one device, strengthening Lupin’s respiratory portfolio and supporting its broader focus on differentiated chronic therapies.